FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2011471738> ?p ?o ?g. }

• W2011471738 endingPage "26" @default.
• W2011471738 startingPage "17" @default.
• W2011471738 abstract "Background: Primary chemotherapy as part of multidisciplinary approach is the established treatment for inoperable stage III B breast cancer. The primary endpoints were conversion to operable disease and feasibility of conservative surgery (breast-conserving therapy: BCT); secondary were clinical and pathological complete response rate, local and distant control and safety of the primary regimen. Methods: Between 1998 and 2001, 40 inoperable breast cancer patients ≤60 years, 72% T4abc and 28% T4d, received 6 cycles of primary PEV dose-dense regimen: cisplatin 50 mg/m2, epirubicin 100 mg/m2 and vinorelbine 25 mg/m2, i.v. (q 14). Modified radical mastectomy (MRM) or BCT was performed, followed by adjuvant chemotherapy, radiotherapy and hormone therapy. Results: All patients were converted to operable disease, and BCT was feasible in 24% of T4abc patients. After a median follow-up of 84 months (range 58–96), local and distant relapses were 7.5% (0% in BCT ) and 25% (25% in BCT), respectively. Clinical response was 80% (clinical complete response [cCR]: 20%); pathological complete response (pCR) was 40% in breast, 50% in axilla (pLN0); 32% both in breast and axilla. Neutropenia (G4, 30%), leukopenia (G4, 25%), alopecia (G2, 100%), nausea and vomiting (G4, 20%) were the most common toxicities. Conclusions: The PEV dose-dense regimen seems to be highly effective in terms of resectability and pCR. Toxicity, mainly hematological, was acceptable. Successful BCT is feasible, in selected patients, without compromising local and distant control." @default.
• W2011471738 created "2016-06-24" @default.
• W2011471738 creator A5000261373 @default.
• W2011471738 creator A5007819365 @default.
• W2011471738 creator A5007854370 @default.
• W2011471738 creator A5010499606 @default.
• W2011471738 creator A5044926112 @default.
• W2011471738 creator A5052376117 @default.
• W2011471738 creator A5068234157 @default.
• W2011471738 creator A5089936869 @default.
• W2011471738 creator A5090814125 @default.
• W2011471738 date "2007-01-01" @default.
• W2011471738 modified "2023-09-24" @default.
• W2011471738 title "Dose-Dense Primary Chemotherapy, as Part of Multidisciplinary Treatment, for Inoperable Stage III B Breast Cancer – Long-Term Results of a Phase II Trial" @default.
• W2011471738 cites W108561042 @default.
• W2011471738 cites W1892756525 @default.
• W2011471738 cites W1964510050 @default.
• W2011471738 cites W1973658923 @default.
• W2011471738 cites W1980000135 @default.
• W2011471738 cites W1982868545 @default.
• W2011471738 cites W1988470760 @default.
• W2011471738 cites W1989644540 @default.
• W2011471738 cites W1993214850 @default.
• W2011471738 cites W1993249767 @default.
• W2011471738 cites W1999933372 @default.
• W2011471738 cites W2001646586 @default.
• W2011471738 cites W2003261885 @default.
• W2011471738 cites W2018669222 @default.
• W2011471738 cites W2029044225 @default.
• W2011471738 cites W2045701290 @default.
• W2011471738 cites W2052123853 @default.
• W2011471738 cites W2059102920 @default.
• W2011471738 cites W2066977665 @default.
• W2011471738 cites W2101122130 @default.
• W2011471738 cites W2101760255 @default.
• W2011471738 cites W2109079833 @default.
• W2011471738 cites W2113137803 @default.
• W2011471738 cites W2124936866 @default.
• W2011471738 cites W2128822091 @default.
• W2011471738 cites W2132434084 @default.
• W2011471738 cites W2136802843 @default.
• W2011471738 cites W2138734774 @default.
• W2011471738 cites W2144090846 @default.
• W2011471738 cites W2153597941 @default.
• W2011471738 cites W2163318274 @default.
• W2011471738 cites W2164361217 @default.
• W2011471738 cites W2167805334 @default.
• W2011471738 cites W2168760093 @default.
• W2011471738 cites W2232616986 @default.
• W2011471738 cites W2287271371 @default.
• W2011471738 cites W4230868220 @default.
• W2011471738 doi "https://doi.org/10.1159/000111084" @default.
• W2011471738 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17998786" @default.
• W2011471738 hasPublicationYear "2007" @default.
• W2011471738 type Work @default.
• W2011471738 sameAs 2011471738 @default.
• W2011471738 citedByCount "3" @default.
• W2011471738 countsByYear W20114717382017 @default.
• W2011471738 crossrefType "journal-article" @default.
• W2011471738 hasAuthorship W2011471738A5000261373 @default.
• W2011471738 hasAuthorship W2011471738A5007819365 @default.
• W2011471738 hasAuthorship W2011471738A5007854370 @default.
• W2011471738 hasAuthorship W2011471738A5010499606 @default.
• W2011471738 hasAuthorship W2011471738A5044926112 @default.
• W2011471738 hasAuthorship W2011471738A5052376117 @default.
• W2011471738 hasAuthorship W2011471738A5068234157 @default.
• W2011471738 hasAuthorship W2011471738A5089936869 @default.
• W2011471738 hasAuthorship W2011471738A5090814125 @default.
• W2011471738 hasConcept C121608353 @default.
• W2011471738 hasConcept C126322002 @default.
• W2011471738 hasConcept C141071460 @default.
• W2011471738 hasConcept C143998085 @default.
• W2011471738 hasConcept C203092338 @default.
• W2011471738 hasConcept C2776694085 @default.
• W2011471738 hasConcept C2780835546 @default.
• W2011471738 hasConcept C2780873365 @default.
• W2011471738 hasConcept C2781413609 @default.
• W2011471738 hasConcept C509974204 @default.
• W2011471738 hasConcept C530470458 @default.
• W2011471738 hasConcept C535046627 @default.
• W2011471738 hasConcept C71924100 @default.
• W2011471738 hasConceptScore W2011471738C121608353 @default.
• W2011471738 hasConceptScore W2011471738C126322002 @default.
• W2011471738 hasConceptScore W2011471738C141071460 @default.
• W2011471738 hasConceptScore W2011471738C143998085 @default.
• W2011471738 hasConceptScore W2011471738C203092338 @default.
• W2011471738 hasConceptScore W2011471738C2776694085 @default.
• W2011471738 hasConceptScore W2011471738C2780835546 @default.
• W2011471738 hasConceptScore W2011471738C2780873365 @default.
• W2011471738 hasConceptScore W2011471738C2781413609 @default.
• W2011471738 hasConceptScore W2011471738C509974204 @default.
• W2011471738 hasConceptScore W2011471738C530470458 @default.
• W2011471738 hasConceptScore W2011471738C535046627 @default.
• W2011471738 hasConceptScore W2011471738C71924100 @default.
• W2011471738 hasIssue "1-2" @default.
• W2011471738 hasLocation W20114717381 @default.
• W2011471738 hasLocation W20114717382 @default.
• W2011471738 hasOpenAccess W2011471738 @default.

• next